logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
I

Igor Gonda

paradigm corporation

41H指数
183论文数
5.4K被引数
收录论文 41
发表时间
logo
Efficacy of Inhalational Ciprofloxacin (Apulmiq) in an NHP Model of Q Fever吸入用环丙沙星（Apulmiq）在Q热非人灵长类动物模型中的疗效
errAntibiotics-Basel
IF4.6
err2026-08-12
err0
errOAAI
errMichelle Nelson; Rachel E. Ireland; Francisco J. Salguero; Stuart J. Armstrong; Thomas R. Laws; James D. Blanchard; Francis Dayton; Igor Gonda; Chad W. Stratilo
err分享
err收藏
Immunological changes associated with the treatment of pneumonic tularaemia in marmosets与治疗肺型土拉热症相关的免疫学变化（在绒猴中）
errFrontiers in Cellular and Infection Microbiology
IF4.8
err2026-04-30
err0
errOAAI
errRE Rachel E. Ireland; AN Alejandro Nunez; JD James D. Blanchard; FD Francis Dayton; IG Igor Gonda; SV Sarah V. Harding; MN Michelle Nelson
err分享
err收藏
Richard William Fuller-The Clinical Scientist Behind the Development of Multiple Leading Inhaled Therapies for Asthma (b. June 29, 1953-d. 2024)理查德·威廉·富勒尔——哮喘领域多种领先吸入疗法开发的临床科学家（生于1953年6月29日，卒于2024年）
errJOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
IF0
err2025-09-01
err0
PREAI
errHickey, Anthony; Gonda, Igor; Atkins, Paul J.
err分享
err收藏
Impact of Flow Restrictors on Aerosol Delivery of the Respimat® Soft Mist Inhaler流控限制器对Respimat®软雾吸入器气溶胶递送的影响
errPULMONARY THERAPY
IF3
err2025-09-01
err0
errOAAI
errFleischhauer, Moritz; Berkenfeld, Kai; Stadermann, David; Velaga, Sitaram; Gonda, Igor; Langguth, Peter; Wachtel, Herbert
err分享
err收藏
Inhaled Medicines: Past, Present, and Future
errPHARMACOLOGICAL REVIEWS
IF17.3
err2022-01-01
err60
errOAAI
errAnderson, Sandra; Atkins, Paul; Baeckman, Per; Cipolla, David; Clark, Andrew; Daviskas, Evangelia; Disse, Bernd; Entcheva-Dimitrov, Plamena; Fuller, Rick; Gonda, Igor; Lundbaeck, Hans; Olsson, Bo; Weers, Jeffry
err分享
err收藏
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
errPHARMACEUTICS
IF5.5
err2021-08-14
err9
errOAAI
errTai, Waiting; Chow, Michael Yee Tak; Chang, Rachel Yoon Kyung; Tang, Patricia; Gonda, Igor; MacArthur, Robert B.; Chan, Hak-Kim; Kwok, Philip Chi Lip
err分享
err收藏
Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and-4 studies
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2020-10-28
err0
errOAAI
errChalmers, James D.; Cipolla, David; Thompson, Bruce; Davis, Angela M.; O'Donnell, Anne; Tino, Gregory; Gonda, Igor; Haworth, Charles; Froehlich, Juergen
err分享
err收藏
Comment on Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2020-10-19
err2
PREAI
errBoushey, Homer; Gonda, Igor
err分享
err收藏
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and-4 studies
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2020-06-18
err34
errOAAI
errChalmers, James D.; Cipolla, David; Thompson, Bruce; Davis, Angela M.; O'Donnell, Anne; Tino, Gregory; Gonda, Igor; Haworth, Charles; Froehlich, Juergen
err分享
err收藏
What kind of emphasis do we need in clinical research to enable personalised respiratory medicine?
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2020-01-16
err1
errOAAI
errGonda, Igor
err分享
err收藏
Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection
errCLINICAL MICROBIOLOGY AND INFECTION
IF8.5
err2019-12-01
err10
errOAAI
errVanDevanter, D. R.; Gonda, I.; Dahms, J.; Cipolla, D.; Davis, A. M.; Chalmers, J. D.; Froehlich, J.
err分享
err收藏
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
errLANCET RESPIRATORY MEDICINE
IF32.8
err2019-03-01
err136
errOAAI
errHaworth, Charles S.; Bilton, Diana; Chalmers, James D.; Davis, Angela M.; Froehlich, Juergen; Gonda, Igor; Thompson, Bruce; Wanner, Adam; O'Donnell, Anne E.
err分享
err收藏
Effect of prior year pulmonary exacerbation (PE) frequency on response to ARD-3150 in patients with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with Pseudomonas aeruginosa (PA)
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2018-11-19
err1
PREAI
errChalmers, James D.; Thompson, Bruce; Froehlich, Juergen; Davis, Angela; Dahms, Janice; Cipolla, David; Gonda, Igor
err分享
err收藏
Reduction of pulmonary exacerbations in two phase 3 Trials: in-depth analyses
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2018-11-19
err1
PREAI
errCipolla, David; Davis, Angela; Froehlich, Juergen; Gonda, Igor; Thompson, Bruce
err分享
err收藏
Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2018-11-19
err1
PREAI
errO'Donnell, Anne; Froehlich, Juergen; Thompson, Bruce; Dahms, Janice; Cipolla, David; Davis, Angela; Gonda, Igor; Haworth, Charles
err分享
err收藏
Open-label extension (OLE) of ORBIT-3 and ORBIT-4 trials of ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB)
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2018-11-19
err3
PREAI
errO'Donnell, Anne; Gonda, Igor; Cipolla, David; Froehlich, Juergen; Davis, Angela; Haworth, Charles
err分享
err收藏
Effective Treatment of Mycobacterium avium subsp hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin
errANTIMICROBIAL AGENTS AND CHEMOTHERAPY
IF4.5
err2018-10-01
err27
errOAAI
errBlanchard, James D.; Elias, Valerie; Cipolla, David; Gonda, Igor; Bermudez, Luiz E.
err分享
err收藏
Late Breaking Abstract - Reduction in frequency of pulmonary exacerbations (PE) with inhaled ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients is independent of Pseudomonas aeruginosa (PA) susceptibility at baseline
errEUROPEAN RESPIRATORY JOURNAL
IF21
err2017-12-06
err2
PREAI
errFroehlich, Juergen; Dahms, Janice; Cipolla, David; Gonda, Igor
err分享
err收藏
Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug
errPHARMACEUTICAL RESEARCH
IF4.3
err2016-07-20
err22
errOAAI
errCipolla, David; Wu, Huiying; Eastman, Simon; Redelmeier, Tom; Gonda, Igor; Chan, Hak-Kim
err分享
err收藏
Development of Liposomal Ciprofloxacin to Treat Lung Infections
errPHARMACEUTICS
IF5.5
err2016-03-01
err156
errOAAI
errCipolla, David; Blanchard, Jim; Gonda, Igor
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
B
Bruce Thompson
H 指数: 142 · 论文数: 2.0K
H
Homer A. Boushey
H 指数: 94 · 论文数: 319
J
James D. Chalmers
H 指数: 94 · 论文数: 1.3K
H
Hak‐Kim Chan
H 指数: 86 · 论文数: 678
S
Sandra D. Anderson
H 指数: 78 · 论文数: 327
查看更多